American Heart Month: Why Pharmacists Are Central to Cardiovascular Prevention

Every February, American Heart Month reminds us of a familiar but uncomfortable truth: Cardiovascular disease remains the leading cause of death in the US. Despite decades of therapeutic innovation, updated clinical guidelines, and public health campaigns, heart disease continues to exert an enormous toll on patients, families, and the health care system. For pharmacists, this month is more than an awareness campaign. It is a call to action.

Heart disease is often framed as inevitable or genetic, but the reality is far more actionable. Hypertension, hyperlipidemia, diabetes, obesity, and smoking are among the most modifiable risk factors, and they are conditions pharmacists encounter daily. Whether in community practice, ambulatory care, or health systems, pharmacists are uniquely positioned at the intersection of access, education, and long-term medication management.

American Heart Month is an opportunity to recenter the conversation on prevention and adherence. Patients do not fail therapies; systems fail patients. Complex regimens, cost barriers, adverse effects, and health literacy gaps all undermine cardiovascular outcomes. Pharmacists routinely identify these barriers before they appear in hospitalization data or mortality statistics. Medication therapy management, refill synchronization, blood pressure screenings, and lipid counseling may seem incremental, but their cumulative impact is profound.

Evidence consistently shows that pharmacist-led interventions improve blood pressure control, lipid management, and medication adherence. Yet these contributions are still underrecognized and underutilized. As cardiovascular care grows more complex—with novel lipid-lowering agents, cardiometabolic therapies, and evolving guidelines—patients need trusted clinicians who can translate evidence into everyday decisions. Pharmacists already do this work; American Heart Month is a moment to make it visible.

Equally important is equity. Cardiovascular disease disproportionately affects underserved communities, where access to primary care may be limited, and we know doctors treat cardiovascular disease less aggressively when their patients are members of communities of color. But pharmacies remain highly accessible, and community pharmacists often serve as the most frequent point of contact for patients managing chronic cardiovascular conditions. Addressing disparities in heart health requires leveraging that access and expanding pharmacists’ ability to practice at the top of their license.

National organizations such as the American Heart Association and the Centers for Disease Control and Prevention continue to emphasize prevention, early intervention, and lifestyle modification. Pharmacists are essential partners in advancing these goals, translating population-level recommendations into personalized, sustainable care.

American Heart Month should not end on February 28. For pharmacists, heart health is a year-round responsibility, rooted in trust, accessibility, and evidence-based care. As cardiovascular disease continues to challenge the health system, the profession’s role is clear: Pharmacists are not peripheral to heart health. They are central to it.